Performance Evaluation Of Lightweight Open-source Large Language Models In Pediatric Consultations: A Comparative Analysis · The Large Language Model Bible Contribute to LLM-Bible

Performance Evaluation Of Lightweight Open-source Large Language Models In Pediatric Consultations: A Comparative Analysis

Wei Qiuhong, Cui Ying, Ding Mengwei, Wang Yanqin, Xiang Lingling, Yao Zhengxiong, Chen Ceran, Long Ying, Jin Zhezhen, Xu Ximing. Arxiv 2024

[Paper]    
Applications GPT Model Architecture Reinforcement Learning Responsible AI

Large language models (LLMs) have demonstrated potential applications in medicine, yet data privacy and computational burden limit their deployment in healthcare institutions. Open-source and lightweight versions of LLMs emerge as potential solutions, but their performance, particularly in pediatric settings remains underexplored. In this cross-sectional study, 250 patient consultation questions were randomly selected from a public online medical forum, with 10 questions from each of 25 pediatric departments, spanning from December 1, 2022, to October 30, 2023. Two lightweight open-source LLMs, ChatGLM3-6B and Vicuna-7B, along with a larger-scale model, Vicuna-13B, and the widely-used proprietary ChatGPT-3.5, independently answered these questions in Chinese between November 1, 2023, and November 7, 2023. To assess reproducibility, each inquiry was replicated once. We found that ChatGLM3-6B demonstrated higher accuracy and completeness than Vicuna-13B and Vicuna-7B (P < .001), but all were outperformed by ChatGPT-3.5. ChatGPT-3.5 received the highest ratings in accuracy (65.2%) compared to ChatGLM3-6B (41.2%), Vicuna-13B (11.2%), and Vicuna-7B (4.4%). Similarly, in completeness, ChatGPT-3.5 led (78.4%), followed by ChatGLM3-6B (76.0%), Vicuna-13B (34.8%), and Vicuna-7B (22.0%) in highest ratings. ChatGLM3-6B matched ChatGPT-3.5 in readability, both outperforming Vicuna models (P < .001). In terms of empathy, ChatGPT-3.5 outperformed the lightweight LLMs (P < .001). In safety, all models performed comparably well (P

.05), with over 98.4% of responses being rated as safe. Repetition of inquiries confirmed these findings. In conclusion, Lightweight LLMs demonstrate promising application in pediatric healthcare. However, the observed gap between lightweight and large-scale proprietary LLMs underscores the need for continued development efforts.

Similar Work